Wednesday ،Jul 24, 2024، 08:36

Soha Pharmaceutical Company’s product portfolio expansion in the research sector is underway/Increased collaboration among subsidiary companies for mutual enhancement is a priority

Soha Pharmaceutical Company’s product portfolio expansion in the research sector is underway/Increased collaboration among subsidiary companies for mutual enhancement is a priority

According to the Public Relations and International Affairs unit of the Medical Procurement Organization, Soha Pharmaceutical Company continues to manufacture and distribute products; tablets, capsules, syrups, and suspensions in compliance with GMP standards and latest WHO regulations. In May of this year alone, nearly 11 million units of pharmaceuticals in different forms were produced and introduced to the market.

 

Enhanced collaboration among subsidiary companies towards synergistic growth is increasingly on the agenda. A memorandum has been signed to strengthen supply chains and sales between Soha Pharmaceutical Company, Helal Iran Medical Devices Company, and the medications provided by Soha Kish Commercial Company.

 

With state-of-the-art facilities in quality control laboratories and research and development, Soha Pharmaceutical Company aims to continually expand its product range. The pharmaceutical research division endeavors to add new products in the fields of supplements, natural products, and traditional remedies. Progress has been made in developing new products in herbal, gastrointestinal, urological, pain relief, and anti-diabetic categories, with updates to follow in due course.

Jun 30, 2024 07:51

Comments

Sender name is required
Email is required
Characters left: 500
Comment is required